Insights from a multisite study utilizing dedicated technology to assess electrical impedance myography as an outcome measure for Duchenne muscular dystrophy

被引：0
|
作者：
Zaidman, C. [1 ]
Kapur, K. [2 ]
Darras, B. [2 ]
Wong, B. [3 ]
Yang, M. [4 ]
Leitner, M. [5 ]
Pazze, L. Dalle [6 ]
Buck, M. [7 ]
Freedman, L. [8 ]
Rutkove, S. [9 ]
机构：
[1] Washington Univ, St Louis, MO USA
[2] Boston Childrens Hosp, Boston, MA USA
[3] Cincinnati Childrens Hosp, Cincinnati, OH USA
[4] Childrens Hosp Colorado, Aurora, CO USA
[5] Accelerating NeuroVentures LLC, Boston, MA USA
[6] Charleys Fund, New York, NY USA
[7] Broad Inst, Boston, MA USA
[8] Myolex Inc, Boston, MA USA
[9] Beth Israel Deaconess MC, Boston, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2018年 / 28卷
关键词：
D O I：
10.1016/j.nmd.2018.06.366
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.318
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 27 条
  • [21] Functional Mixed-Effects Modeling of Longitudinal Duchenne Muscular Dystrophy Electrical Impedance Myography Data Using State-Space Approach
    Kapur, Kush
    Sanchez, Benjamin
    Pacheck, Adam
    Darras, Basil
    Rutkove, Seward B.
    Selukar, Rajesh
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2019, 66 (06) : 1761 - 1768
  • [22] ELECTRICAL-IMPEDANCE IN THE LOWER-LIMBS OF PATIENTS WITH DUCHENNE MUSCULAR-DYSTROPHY - A PRELIMINARY-STUDY
    NOSHIRO, M
    MORIMOTO, T
    NAGAO, H
    MATSUDA, H
    MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 1993, 31 (02) : 97 - 102
  • [23] Toward patient-centered treatment goals for duchenne muscular dystrophy: insights from the “Your Voice” study
    Carolyn E. Schwartz
    Skyler Jackson
    James Valentine
    Natalie Miller
    Linda Lowes
    Danielle Edwards
    Christine McSherry
    Dimitrios Savva
    Alex Lowe
    Jordan McSherry
    Patti Engel
    Orphanet Journal of Rare Diseases, 18
  • [24] Toward patient-centered treatment goals for duchenne muscular dystrophy: insights from the "Your Voice" study
    Schwartz, Carolyn E.
    Jackson, Skyler
    Valentine, James
    Miller, Natalie
    Lowes, Linda
    Edwards, Danielle
    McSherry, Christine
    Savva, Dimitrios
    Lowe, Alex
    McSherry, Jordan
    Engel, Patti
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [25] INSIGHTS, NEEDS, AND PERSPECTIVES FROM PATIENTS, CAREGIVERS, AND HEALTHCARE PROFESSIONALS ON SHARED DECISION MAKING IN DUCHENNE MUSCULAR DYSTROPHY: A QUALITATIVE STUDY
    Schoefs, E.
    Lerinckx, E.
    Desmet, T.
    De Waele, L.
    Geuens, S.
    Pelicaen, C.
    Meeus, L.
    Mommen, M.
    Janssens, R.
    Huys, I
    VALUE IN HEALTH, 2023, 26 (12) : S472 - S472
  • [26] Potential benefits of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: insights from a preclinical study in the D2-mdx mouse
    Mantuano, P.
    Boccanegra, B.
    Cappellari, O.
    Mele, A.
    Marinelli, M.
    Cristiano, E.
    Tulimiero, L.
    Conte, E.
    Torsello, A.
    Denoyelle, S.
    Liantonio, A.
    De Luca, A.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [27] Bioanalysis of a double blind, placebo-controlled clinical phase 2 study of drisapersen for the treatment of boys suffering from Duchenne muscular dystrophy and comparison to clinical outcome results
    Lourbakos, A.
    Beekman, C.
    Holling, T.
    Testerink, J.
    Duinsbergen, D.
    Giannakopoulos, S.
    Morgan, A.
    van Deutekom, J.
    Campion, G.
    Rolfe, K.
    Kraus, J.
    Hood, S.
    de Kimpe, S.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 805 - 805
123